Clinical Trial

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

Study acronym: SHINE-HF
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to conduct a multicenter, randomized clinical trial to evaluate the effect of "ShengXian-QuYu Decoction" on quality of life , symptoms, and biomarkers in heart failure patients with reduced and mildly reduced ejection fraction.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2022-10-13; most recent amendment 2025-04-04.
Status change: Not Yet Recruiting → Recruiting 2023-03-29
Trial Details
NCT Number NCT05583773
Lead Sponsor China-Japan Friendship Hospital
Conditions Heart Failure
Enrollment 336 participants
Start Date 2023-03-29
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-08